| Range: | 5.45-18.15 | Vol Avg: | 70879 | Last Div: | 0 | Changes: | 0.7 |
| Beta: | 1.8 | Cap: | 0.29B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Apr 22 2021 | Empoloyees: | 184 | ||
| CUSIP: | 641288105 | CIK: | 0001528287 | ISIN: | US6412881053 | Country: | US |
| CEO: | Mr. Joel D. Becker | Website: | https://www.neuropace.com | ||||
NPCE 9.70 Stock Price NeuroPace, Inc.
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow